Blockade with methadone, cyclazocine, and naloxone.
D000700:Analgesics / Q000627:therapeutic use*; D001392:Azocines / Q000627:therapeutic use*; D003496:Cyclazocine / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D003932:Heroin; D006760:Hospitalization; D006769:Hospitals, General; D006784:Hospitals, Teaching; D006801:Humans; D008691:Methadone / Q000008:administration & dosage / Q000627:therapeutic use*; D009019:Morphinans / Q000627:therapeutic use*; D009021:Morphine Dependence / Q000628:therapy; D009270:Naloxone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009294:Narcotics; D009519:New York City; D010044:Outpatient Clinics, Hospital; D011613:Psychotherapy; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control; D019966:Substance-Related Disorders / Q000628:therapy*
D000700:Analgesics; D001392:Azocines; D009019:Morphinans; D009292:Narcotic Antagonists; D009294:Narcotics; D009270:Naloxone; D003932:Heroin; D003496:Cyclazocine; D008691:Methadone